Table 2.
Clinical parameters of cohort 2.
| Obese without T2D | Obese T2D | |||||
|---|---|---|---|---|---|---|
| Women | Men | p-value | Women | Men | p-value | |
| Sample No | 29 | 10 | 22 | 9 | ||
| Age (years) | 45 ± 11 (25 - 63) |
45 ± 12 (22 - 59) |
0.817 | *40 - 62 (31 - 65) |
55 ± 10 (39 - 67) |
0.401 |
| BMI (kg/m2) | 47 ± 5 (39 - 57) |
47 ± 7 (37 - 58) |
0.760 | 51 ± 7 (33 - 64) |
46 ± 8 (38 - 58) |
0.140 |
| TG (mmol/L) | 1.1 ± 0.4 (0.18 - 2.0) |
*0.9 -1.6 (0.8-5) |
0.273 | *1.3 - 2.3 (0.6 - 11.2) |
1.5 ± 0.6 (0.8 - 2.3) |
0.395 |
| Fasting insulin (μIU/L) | *11.1 - 27.6 (3.6 - 88.5) | 15.1 ± 8.2 (3.8 - 30.2) | 0.378 | *15.1 - 46.8 (2.7 - 98.9) | *7.6 - 19.9 (2.2 - 111.3) | 0.103 |
| Fasting glucose(mmol/L) | *4.7 - 5.6 (4.1 - 10.4) | 5.4 ± 0.8 (4.4 - 7.3) | 0.606 | 7.4 ± 1.9 (4.5 - 12.1) | *5.6 - 7.1 (5.2 - 13.4) | 0.287 |
| HbA1C (mmol/mol) | 35.1 ± 4.5 (27.9 - 47.7)) |
*35.5 - 39.4 (32.2 - 54.2) |
0.072 | *43.1 - 52.2 (34.5 - 86) |
47 ± 10 (38 - 64.4) |
0.402 |
| HOMA-IR | *2.10 - 6.1 (0.64 - 18.4) |
2.3 ± 1.4 (0.5 - 4.3) |
0.073 | *3.8 - 14 (0.6 - 30.5) |
*3.7 - 6.8 (2.6 - 58.4) |
0.321 |
For normally distributed values, the mean ± SD with minimal and maximal values is shown. For non–normally distributed values (indicated with *), median–interquartile range with minimal and maximal values is indicated. Unpaired parametric (t-test) and non-parametric (Mann-Whitney)-tests were used to test the significance between men and women for normally and non-normally distributed (indicated with*) values, respectively.